RECRUITINGINTERVENTIONAL
Evaluating Modulation Effects of Temporal Interference Using SEEG
About This Trial
This single-center prospective study aims to investigate the electrophysiological mechanisms of temporal interference (TI) in humans by analyzing clinical, imaging, and electrophysiological data from patients aged 14-60 with drug-resistant epilepsy.
Who May Be Eligible (Plain English)
Who May Qualify:
- Clinical diagnosis of drug-resistant epilepsy;
- No severe systemic diseases;
- Implantation of stereotactic electrodes;
- Agreement to participate in this study and signs the willing to sign a consent form form.
Who Should NOT Join This Trial:
- Hematoma at the scalp electrode site or fluid accumulation under the electrode after intracranial electrode placement.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Clinical diagnosis of drug-resistant epilepsy;
* No severe systemic diseases;
* Implantation of stereotactic electrodes;
* Agreement to participate in this study and signs the informed consent form.
Exclusion Criteria:
* Hematoma at the scalp electrode site or fluid accumulation under the electrode after intracranial electrode placement.
Treatments Being Tested
OTHER
Temporal Interference
Researchers applied temporal interference (TI) stimulation to the deep brain nuclei of patients who had undergone SEEG monitoring, recording changes in electrical activity detected by SEEG.
Locations (1)
Xuanwu Hospital,Capital Medical University
Beijing, Beijing Municipality, China